Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Noah Simon

7PUBLICATIONS
26CO-AUTHORS
Haematological tumoursMolecular evolutionMolecular targetsPredictive and prognostic markersContext learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|May 16, 2025
Accounting for Inconsistent Use of Covariate Adjustment in Group Sequential Trials.

Marlena S Bannick, Sonya L Heltshe, Noah Simon

|Dec 09, 2024
Thrifty wide-context models of B cell receptor somatic hypermutation.

Kevin Sung, Mackenzie M Johnson, Will Dumm

|Jun 25, 2024
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application.

Mark N Warden, Sonya L Heltshe, Noah Simon

|Jun 03, 2023
Considerations for identifying the "right" subgroup in adaptive enrichment trials.

Noah Simon

|Nov 02, 2022
The Impact of Time Horizon on Classification Accuracy: Application of Machine Learning to Prediction of Incident Coronary Heart Disease.

Steven Simon, Divneet Mandair, Abdel Albakri

|Jun 12, 2020
Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.

Amalia S Magaret, Shevin T Jacob, M Elizabeth Halloran

Pageof 2

Frequent Collaborators

2 joint publications

Amalia S Magaret

1 joint publications

Shevin T Jacob

1 joint publications

M Elizabeth Halloran

1 joint publications

Katherine A Guthrie

1 joint publications

Craig A Magaret

1 joint publications

Christine Johnston

1 joint publications

Anna Wald

1 joint publications

Steven Simon

1 joint publications

Divneet Mandair

1 joint publications

Abdel Albakri

Frequent Collaborators

2 joint publications

Amalia S Magaret

1 joint publications

Shevin T Jacob

1 joint publications

M Elizabeth Halloran

1 joint publications

Katherine A Guthrie

Top Related Videos

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on : May 13, 2022

5.8K
Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on : Apr 20, 2021

6.6K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.3K
See more related videos

Top Related Videos

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on : May 13, 2022

5.8K
Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on : Apr 20, 2021

6.6K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.3K
See more related videos